ONCOGENEX PHARMACEUTICALS, INC. 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed May 24, 2016
Insider Transaction Report
Form 4
GOLDSTEIN JACK
Director
Transactions
- Exercise/Conversion
Common Stock
2016-05-20+5,000→ 17,500 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2016-05-20−5,000→ 0 totalFrom: 2016-05-20→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
- [F2]RSUs convert into common stock on a one-for-one basis.
- [F3]Each RSU represents a contingent right to receive one share of the issuer's common stock.
- [F4]The RSUs expire 30 days from the date they vest.